As an undergraduate researcher at UNC at Chapel Hill and NIH, I gained a broad understanding of biological mechanisms underlying disease, especially cancer. My experiences while designing an undergraduate course, research work, and clinical volunteering sparked my interest in genomics and precision medicine. My coursework and clinical experiences during my master's in genomic medicine at Imperial College London demonstrated to me the potential of precision medicine to revolutionize healthcare. As an MD/PhD student, I will study the genomic landscape of paragangliomas, pheochromocytomas, and gastrointestinal stromal tumors at the NIH and the University of Cambridge. Through metabolic, epigenetic, and functional genomic studies, I hope to elucidate the biological underpinnings of these devastating neuroendocrine tumors, leading to advancements in prognostication and treatment. Outside the lab, I will continue my involvement in scientific outreach/education and refugee health. I am honored to be part of the multidisciplinary and collaborative Gates Cambridge community seeking to improve global society. As a future physician-scientist, I aspire to translate scientific advancements into precision medicine diagnostics and therapeutics.
University of North Carolina Medicine 2026
Imperial College London (University of London) Genomic Medicine 2017
The University of North Carolina at Chapel Hill Biology 2016